Monthly Archives: January 2022

Riboflavin biosynthetic pathway: A potent antitubercular drug target

Post Image

Tuberculosis (TB) is one of the leading causes of death, according to the World Health Organization report a total of 1.5 million people died from TB in 2020 and its the second leading infectious killer after COVID-19 (above HIV/AIDS). TB is caused from a Mycobacterium tuberculosis (M. tuberculosis) bacterium. The increase in M. tuberculosis drug […]

Share
Read more